[Studies on absorption, biotransformation and excretion of drug. VIII. Metabolic fate of a new analgesic and anti-inflammatory agent, 2-oxo-3-[4-(1-oxo-2-isoindolinyl)phenyl]-butanamide (OIB) in rats].
D000284:Administration, Oral; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000378:metabolism*; D001646:Bile / Q000378:metabolism; D001711:Biotransformation; D005243:Feces / Q000032:analysis; D007211:Indoles / Q000008:administration & dosage / Q000378:metabolism*; D054833:Isoindoles; D008297:Male; D051381:Rats
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007211:Indoles; D054833:Isoindoles; C033477:2-oxo-3-(4-(1-oxo-2-isoindolinyl)phenyl)butanamide